## Clinical Scenario Analysis This patient presents with **passive suicidal ideation without plan or intent**, on a subtherapeutic antidepressant dose (sertraline 50 mg is below the therapeutic range of 50–200 mg), with significant psychosocial stressors. The key question is: **Does she require hospitalization, or can she be managed as an outpatient with intensified monitoring?** ## Suicide Risk Assessment Framework **High-Yield:** Risk stratification distinguishes **passive ideation** ("I wish I were dead") from **active ideation with plan/intent** ("I will hang myself tonight"). ### Risk Factors Present - Suicidal ideation (2 weeks duration) ✓ - Major depression ✓ - Social isolation (lives alone) ✓ - Poor support network ✓ - Unemployment (loss of structure/identity) ✓ ### Protective Factors Present - No prior attempts ✓ - No specific plan or intent ✓ - Engaged in treatment (attending clinic) ✓ - Subtherapeutic medication dose (room for optimization) ✓ ## Why the Correct Answer is Right **Key Point:** The management of suicidal ideation depends on **risk level**, not ideation alone. A formal, documented risk assessment is mandatory and guides the level of care. **Clinical Pearl:** Passive ideation in early antidepressant treatment (1 month on subtherapeutic dose) often improves with dose escalation and time. However, the **black box warning** (FDA 2004) notes SSRIs can increase suicidality in the first 2–4 weeks, especially in young adults. This patient requires close monitoring. **Mnemonic: RAMP** (Risk Assessment, Medication Optimization, Monitoring, Protective factors) - **R**isk assessment: detailed (intent, plan, access to means, prior attempts) - **A**ntidepressant: increase dose (sertraline 50 → 100 mg is reasonable) - **M**onitoring: weekly contact (phone or in-person) until stable - **P**rotective factors: engage social support, consider day programs If the risk assessment reveals **high-risk features** (specific plan, intent, access to means, prior attempts, or acute worsening), hospitalization is indicated. If **low-to-moderate risk**, outpatient management with dose escalation and close monitoring is appropriate. ## Why Other Options Fail | Option | Flaw | |--------|------| | Increase sertraline and follow-up in 2 weeks | **Too passive.** Two-week intervals are unsafe for active suicidal ideation. No formal risk assessment. Monitoring is inadequate. | | Refer to ED for involuntary admission | **Premature.** No indication for involuntary hospitalization without high-risk features (plan, intent, access). This violates the principle of least restrictive care. | | Prescribe alprazolam and weekly follow-up | **Dangerous.** Benzodiazepines increase disinhibition and suicide risk, especially with antidepressants. Monotherapy with a sedative is not standard. Weekly monitoring is too infrequent for active ideation. | ## Hospitalization Criteria (When to Admit) **Urgent admission indicated if:** - Specific, detailed plan (method, time, place) - Intent to act ("I will do it") - Access to means (gun, pesticide, medication stockpile) - Prior suicide attempts - Acute psychiatric symptoms (command hallucinations, severe agitation) - Severe hopelessness or despair - Lack of social support or unsafe living situation **This patient has NONE of these.** Outpatient management with optimization is appropriate. ## Safety Planning for Outpatient Management 1. **Dose escalation:** Sertraline 50 → 100 mg (therapeutic range) 2. **Frequency of contact:** Weekly phone or in-person visits for 4 weeks 3. **Crisis plan:** Provide emergency hotline, crisis team number, ED contact 4. **Means restriction:** Discuss access to lethal means (medications, pesticides, weapons) 5. **Psychotherapy:** Refer for cognitive-behavioral therapy (CBT) or interpersonal therapy (IPT) 6. **Social engagement:** Encourage day programs, peer support, family involvement
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.